Samsung Electronics says it is in talks with major tech companies for its next-generation 2nm chip manufacturing process, a direct challenge to TSMC's market leadership.
Back
Samsung Electronics says it is in talks with major tech companies for its next-generation 2nm chip manufacturing process, a direct challenge to TSMC's market leadership.

Samsung Electronics is positioning its 2-nanometer (2nm) semiconductor process to win contracts from major technology companies, signaling a direct challenge to Taiwan Semiconductor Manufacturing Co. (TSMC) in the next generation of advanced chipmaking. The company announced on Thursday it is in active discussions for foundry deals that could shift the competitive landscape, particularly as the artificial intelligence (AI) boom drives insatiable demand for more powerful and efficient processors.
"We are in talks with big tech customers regarding the foundry contracts," Samsung Electronics said in a statement on April 29, 2026, adding it expects to win more deals for its 2nm process in the near future.
While Samsung did not disclose specific customer names, the announcement targets the heart of TSMC's current market dominance. TSMC currently holds a staggering 72.3% market share in advanced-node manufacturing (5nm and below), producing the cutting-edge chips that power AI leaders like Nvidia and AMD. Samsung's 2nm process, which packs more transistors into a smaller area to boost performance and power efficiency, is its bid to close that gap. The company is emphasizing the maturity and yield stability of its 4nm FinFET process as a stepping stone to its 2nm technology, aiming to attract clients who are currently reliant on TSMC for their most advanced designs.
This move could have significant implications for the semiconductor supply chain and the pricing of AI hardware. If Samsung can secure a major customer like Nvidia or a large cloud provider for its 2nm process, it would not only represent a multi-billion dollar revenue stream but also reduce the industry's dependence on a single foundry. For investors, this signals a potential shift in market share, with Samsung's foundry business poised to capture a larger piece of the high-margin advanced node market, currently valued at over $100 billion.
The surge in demand for AI infrastructure has created a manufacturing bottleneck at the most advanced process nodes. While chip designers like Nvidia and AMD have been the primary beneficiaries of the AI boom in terms of stock performance, their ability to meet demand is fundamentally constrained by the production capacity of foundries like TSMC. As AI models become larger and more complex, the need for chips with higher transistor density and greater power efficiency has accelerated the transition to smaller process nodes, from 5nm to 3nm and now to the emerging 2nm standard.
This has created a critical opening for Samsung. While TSMC has been the undisputed leader, its capacity is finite. Large tech companies are increasingly looking to diversify their supply chains to mitigate single-source risk, a vulnerability that has become more apparent amid geopolitical tensions and supply chain disruptions. Samsung's recent eightfold surge in profits, driven by the memory chip crunch from the AI boom, provides it with the capital to invest heavily in its foundry business and compete directly with TSMC for the most lucrative contracts.
While TSMC remains the dominant force in the foundry market, Samsung's aggressive push into the 2nm space presents a credible long-term challenge. For investors, the key metric to watch will be the announcement of a major design win for Samsung's 2nm process from a large-scale customer. Such a deal would validate its technology and signal a meaningful shift in the competitive dynamics of the semiconductor industry. While TSMC's stock has performed well, Samsung's potential to capture even a fraction of the advanced-node market from its rival could unlock significant value for its shares.
This article is for informational purposes only and does not constitute investment advice.